Axsome Therapeutics's total assets for Q4 2024 were $568.50M, an increase of 1.25% from the previous quarter. AXSM total liabilities were $511.48M for the fiscal quarter, a 9.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.